{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T12:06:16Z","timestamp":1790683576541,"version":"4.1.0"},"reference-count":19,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.vaccine.2013.04.040","type":"journal-article","created":{"date-parts":[[2013,12,10]],"date-time":"2013-12-10T00:16:29Z","timestamp":1386634589000},"page":"K7-K11","source":"Crossref","is-referenced-by-count":7,"special_numbering":"S10","title":["A systematic review of validated methods for identifying Bell's palsy using administrative or claims data"],"prefix":"10.1016","volume":"31","author":[{"given":"Christopher D.","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan M.","family":"Carnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa L.","family":"McPheeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"January (Suppl. 1)","key":"10.1016\/j.vaccine.2013.04.040_bib0005","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/pds.2323","article-title":"The Food and Drug Administration's Post-Licensure Rapid Immunization Safety Monitoring program: strengthening the federal vaccine safety enterprise","volume":"21","author":"Nguyen","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"January (Suppl. 1)","key":"10.1016\/j.vaccine.2013.04.040_bib0010","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1002\/pds.2321","article-title":"Mini-Sentinel's systematic reviews of validated methods for identifying health outcomes using administrative and claims data: methods and lessons learned","volume":"21","author":"Carnahan","year":"2012","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"April (18)","key":"10.1016\/j.vaccine.2013.04.040_bib0015","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.vaccine.2012.02.057","article-title":"Health outcomes of interest for evaluation in the Post-Licensure Rapid Immunization Safety Monitoring Program","volume":"30","author":"Lieu","year":"2012","journal-title":"Vaccine"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.04.040_bib0020","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/aje\/kwf009","article-title":"Effects of climate, latitude, and season on the incidence of Bell's palsy in the US Armed Forces, October 1997 to September 1999","volume":"156","author":"Campbell","year":"2002","journal-title":"Am J Epidemiol"},{"issue":"January (1)","key":"10.1016\/j.vaccine.2013.04.040_bib0025","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1046\/j.1468-1331.2002.00343.x","article-title":"The epidemiology and treatment of Bell's palsy in the UK","volume":"9","author":"Rowlands","year":"2002","journal-title":"Eur J Neurol"},{"issue":"1","key":"10.1016\/j.vaccine.2013.04.040_bib0030","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/j.1749-4486.2010.02084.x","article-title":"Bell's palsy: a review of three systematic reviews of steroid and anti viral therapy","volume":"35","author":"Browning","year":"2010","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/j.vaccine.2013.04.040_bib0035","first-page":"CD001942","article-title":"Corticosteroids for Bell's palsy (idiopathic facial paralysis)","volume":"3","author":"Salinas","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"47","key":"10.1016\/j.vaccine.2013.04.040_bib0040","doi-asserted-by":"crossref","DOI":"10.3310\/hta13470","article-title":"A randomised controlled trial of the use of aciclovir and\/or prednisolone for the early treatment of Bell's palsy: the BELLS study","volume":"13","author":"Sullivan","year":"2009","journal-title":"Health Technol. Assess."},{"key":"10.1016\/j.vaccine.2013.04.040_bib0045","doi-asserted-by":"crossref","first-page":"d5956","DOI":"10.1136\/bmj.d5956","article-title":"Neurological and autoimmune disorders after vaccination against pandemic influenza A (H1N1) with a monovalent adjuvanted vaccine: population based cohort study in Stockholm","volume":"343","author":"Bardage","year":"2011","journal-title":"Sweden. BMJ"},{"issue":"9","key":"10.1016\/j.vaccine.2013.04.040_bib0050","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa030595","article-title":"Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland","volume":"350","author":"Mutsch","year":"2004","journal-title":"N Engl J Med"},{"issue":"December (1)","key":"10.1016\/j.vaccine.2013.04.040_bib0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.vaccine.2007.10.043","article-title":"All that palsies is not Bell's -the need to define Bell's palsy as an adverse event following immunization","volume":"26","author":"Rath","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.04.040_bib0060","unstructured":"McPheeters M, Sathe N, Jerome R, Carnahan R. Methods for Systematic Reviews of Administrative Database Studies Capturing Health Outcomes of Interest Vaccine, in press."},{"issue":"6","key":"10.1016\/j.vaccine.2013.04.040_bib0065","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1159\/000110333","article-title":"Incidence and risk factors for Bell's palsy in LaredoTexas: 1974\u20131982","volume":"12","author":"Brandenburg","year":"1993","journal-title":"Neuroepidemiology"},{"issue":"4","key":"10.1016\/j.vaccine.2013.04.040_bib0070","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1159\/000338303","article-title":"Epidemiologic and clinical features of Bell's palsy among children in Northern California","volume":"38","author":"Rowhani-Rahbar","year":"2012","journal-title":"Neuroepidemiology"},{"issue":"May (9)","key":"10.1016\/j.vaccine.2013.04.040_bib0075","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1093\/aje\/kws011","article-title":"Immunization and Bell's palsy in children: a case-centered analysis","volume":"175","author":"Rowhani-Rahbar","year":"2012","journal-title":"Am J Epidemiol"},{"issue":"May (5)","key":"10.1016\/j.vaccine.2013.04.040_bib0080","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1365-2796.2011.02474.x","article-title":"Safety of zoster vaccine in adults from a large managed-care cohort: a Vaccine Safety Datalink study","volume":"271","author":"Tseng","year":"2012","journal-title":"J Intern Med"},{"issue":"9707","key":"10.1016\/j.vaccine.2013.04.040_bib0085","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0140-6736(09)61877-8","article-title":"Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines","volume":"374","author":"Black","year":"2009","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.vaccine.2013.04.040_bib0090","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1159\/000314345","article-title":"Door-to-door survey of major neurological disorders in Al Kharga District, New Valley, Egypt: methodological aspects","volume":"35","author":"El Tallawy","year":"2010","journal-title":"Neuroepidemiology"},{"issue":"July (1)","key":"10.1016\/j.vaccine.2013.04.040_bib0095","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1600-0404.1996.tb00043.x","article-title":"Incidence and lifetime prevalence of Bell's palsy in two Sicilian municipalities. Sicilian Neuro-Epidemiologic Study (SNES) Group","volume":"94","author":"Savettieri","year":"1996","journal-title":"Acta Neurol Scand"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004817?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13004817?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T04:27:24Z","timestamp":1538972844000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13004817"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":19,"alternative-id":["S0264410X13004817"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.04.040","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]}}}